Riskpilot← Back to searchSign inGet full accessHYPOSKIN ApS
APSActiveCVR 34226083Estrupvej 11Manufacture of pharmaceutical preparations · NACE 2120Est. 2012— employees
Revenue 2025
—
EBITDA margin
—
+15% vs 2024
Equity ratio
-31812.2%
Financial strength
Net profit 2025
DKK -205K
-221% vs 2024
| Revenue | — | — |
| EBITDA | DKK -60K | +15% |
| Net profit | DKK -205K | -221% |
| Total assets | DKK 11K | -94% |
| Equity | DKK -3,6M | -6% |
| Employees | — | — |
Legal name
HYPOSKIN ApS
CVR number
34226083
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
7. februar 2012
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle projekter og drive disse samt udøve handelsvirksomhed.
Address
Estrupvej 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -825 | — | — | -341 | -66 | -147 | -89 | -69 | -50 | -60 | — | -70 | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -825 | -830 | -58 | -341 | -66 | -147 | -89 | -69 | -50 | -60 | -61 | -70 | -60 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -825 | -830 | -58 | -341 | -66 | -147 | -89 | -69 | -50 | -60 | -61 | -70 | -60 |
| Net financials | -33 | -47 | -77 | -100 | -112 | -122 | -137 | -141 | -150 | -161 | -165 | -171 | -146 |
| Profit before tax | -858 | -877 | -136 | -441 | -178 | -269 | -225 | -210 | -200 | -221 | -226 | -241 | -205 |
| Tax | -215 | 215 | -0 | -75 | -15 | -2 | -20 | -4 | -197 | -5 | -77 | -177 | -0 |
| Net profit | -644 | -1.091 | -136 | -366 | -164 | -267 | -206 | -206 | -3 | -216 | -149 | -64 | -205 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 374 | 30 | 106 | 103 | 100 | 121 | 58 | 26 | 209 | 220 | 99 | 196 | 11 |
| Equity | -564 | -1.655 | -1.791 | -2.157 | -2.321 | -2.587 | -2.793 | -3.000 | -3.002 | -3.218 | -3.367 | -3.431 | -3.636 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 938 | 1.685 | 1.897 | 2.260 | 2.421 | 2.708 | 2.851 | 3.026 | 3.211 | 3.438 | 3.466 | 3.627 | 3.648 |
| Total debt | 938 | 1.685 | 1.897 | 2.260 | 2.421 | 2.708 | 2.851 | 3.026 | 3.211 | 3.438 | 3.466 | 3.627 | 3.648 |
EBITDA margin
-5981600.0%
This company
15.8%
Market median
-37858328% vs market
20132025
Equity ratio
-31812.2%
This company
38.2%
Market median
-83378% vs market
20132025
Return on equity
-20537500.0%
This company
18.4%
Market median
-111616948% vs market
20132025
Net profit margin
-20537500.0%
This company
8.1%
Market median
-253549483% vs market
20132025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-02-07 – 2013-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JU Management | Management | 2013 | — | — |
BT Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SPECIALLÆGEHOLDINGSELSKABET JUF HOLSTEBRO ApS | Company | 66.7% | 66.7% | 2012 |
KREN HOLDING ApS | Company | 10.0% | 10.0% | 2012 |
| Individual | 5.0% | 5.0% | 2012 | |
HOBINN HOLDING ApS | Company | 5.0% | 5.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KREN HOLDING ApS
HYPOSKIN ApS Board members of HYPOSKIN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Ulrik Felding | Management | 0 companies |
| Brian Thomsen Nielsen | Management | 0 companies |
| Ulrik Ascanius Tvede Felding | Board of Directors | 0 companies |
| Kren Erik Whittard Nielsen | Board of Directors | 0 companies |